Jastinib 5 Mg

Name: Jastinib 5 Mg
Brand: Maheshwari Medical Agency
Price: 2300 INR
Availability: InStock

Price 2300 INR/ Pack

Get a Price/Quote

MOQ : 2 Packs

Jastinib 5 Mg Specification

Indication
Treatment of myelofibrosis and polycythemia vera

Dosage Form
Tablets

Salt Composition
Axitinib Tablet

Enzyme Types
Janus kinase inhibitor (JAK1 and JAK2)

Feature
Targeted therapy for specific blood disorders

Ingredients
Other

Application
Oral administration

Ph Level
Neutral

Physical Color/Texture
White to off-white, round tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibition of JAK1 and JAK2 activity

Storage Instructions
Keep dry & cool place

Shelf Life
24 Months

Caution
Keep out of reach of children

Brand Name
Jastinib 5 mg

Therapeutic Class
Antineoplastic agents

Warning
To be sold by retail on the prescription of an oncologist only

Packing Size
1 x 10 tablets strip

Route of Administration
Oral

Marketed By
Jasco Labs Pvt Ltd

Prescription Status
Prescription only

Packaging Type
Blister pack

Jastinib 5 Mg Trade Information

Minimum Order Quantity
2 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

About Jastinib 5 Mg

Experience the kingly confidence of targeted treatment with Jastinib 5 mg-your splendid choice for managing myelofibrosis and polycythemia vera. Each dazzling white-to-off-white tablet, packed in a secure blister strip (1 x 10 tablets), is carefully crafted by Jasco Labs Pvt Ltd. As a Janus kinase inhibitor, Jastinib delivers precision therapy with prescription-only assurance. Swiftly add to cart, but remember: this product is for sale strictly on an oncologist's prescription. Store cool, keep safe, and pick yours today for dazzling results!

Targeted Therapy for Complex Blood Disorders

Jastinib 5 Mg is specifically designed for adults undergoing treatment for myelofibrosis and polycythemia vera, making it a vital addition for both specific and general oncological care. The tablets provide targeted inhibition of JAK1 and JAK2 enzymes, minimizing harmful activity while keeping therapeutic focus. With splendid oral administration, its dazzling white, round form ensures easy usage, perfectly suited for prescribed regimes. This prescription-only product is a crucial component for enhancing patient care in specialized environments.

Sample Availability and Export Details

Jastinib 5 Mg sample requests are welcomed to facilitate informed clinical choices. Our efficient packing & dispatch operations ensure that orders are processed swiftly, with delivery time tailored to customer needs. Available for sale at a competitive price, export charges apply based on market and shipping destination. Serving clients across India and international markets, we pride ourselves as a reliable distributor, supplier, and trader, maintaining top standards throughout every transaction.

FAQ's of Jastinib 5 Mg:

Q: How should Jastinib 5 mg tablets be administered for optimal results?

A: Jastinib 5 mg should be taken orally, exactly as prescribed by your oncologist. Do not alter the dosage without professional guidance, and always follow the instructions for administration and storage.

Q: What are the primary conditions treated with Jastinib 5 mg?

A: Jastinib 5 mg is indicated for the treatment of myelofibrosis and polycythemia vera, both of which are complex blood disorders targeted by JAK1 and JAK2 inhibition.

Q: When can I expect delivery of Jastinib 5 mg after placing an order?

A: Delivery times vary based on your location, but our packing & dispatch team ensures orders are shipped promptly to support timely access for patients and healthcare providers.

Q: Where can I purchase Jastinib 5 mg tablets?

A: Jastinib 5 mg is available through licensed distributors, suppliers, and traders across India and select export markets. It is sold strictly via prescription from an oncologist.

Q: What are the handling and storage recommendations for Jastinib 5 mg?

A: Keep Jastinib 5 mg tablets in a dry, cool place, away from direct sunlight and out of reach of children. Always store the tablets in their original blister pack until use for maximum efficacy.

Q: How does Jastinib 5 mg benefit patients compared to other therapies?

A: Its targeted inhibition of JAK1 and JAK2 enzymes allows Jastinib 5 mg to specifically address the underlying mechanisms of myelofibrosis and polycythemia vera, potentially reducing symptoms and improving quality of life under supervised treatment.

Tell us about your requirement